Spirea, a startup supported by the Accelerate Cambridge programme run by Cambridge Judge Business School’s Entrepreneurship Centre, has secured funding of £2.4 million with investments from high-profile UK and US investors.
Dr Myriam Ouberai, Chief Executive Officer at Spirea, commented:…
Spirea startup, supported by the Accelerate Cambridge programme run by Cambridge Judge’s Entrepeneurship Centre, has raised crucial funding and is aiming to target a potential $7.5 billion market for the treatment of multiple cancers. CEO Myriam Ouberai said: “Incorporation of…
BioBeat has released its 50 Movers and Shakers in BioBusiness 2018 list of female leaders in healthcare, which includes several women with Cambridge Judge connections. They include Miriam Ouberai of SPIREA, Zuzanna Brzosko of Sixfold Bioscience, and Anya Roy of…
Journal article on peptides co-authored by the co-founder of Accelerate Cambridge healthcare venture wins MedImmune 2017 Global Excellence Award for best publication.
A journal article on peptides co-authored by the co-founder of a healthcare technology venture mentored on the Accelerate…
